Prevention of urological complications in living kidney transplantation: stenting or not?

Recruiting

• Conditions: nier transplantatie; kidney transplantation; urological complications

• Registration Number: NL-OMON41447
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

Participants who will receive a living donor kidney transplantation and speak the Dutch language sufficiently to sign the informed consent forms and to fill in the questionnaires.

Exclusion Criteria

- Patients with a reconstructed urinary tract or conduit after total or partial cystectomy.
- Patients with bladder dysfunction that requires continuous or intermittent catheterization.
- Age <18 years
- Donor kidneys with more than one ureter

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Percutaneous Nephrostomy placement</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Urinary tract infection<br /><br>Haematuria<br /><br>Radiological interventions<br /><br>Surgical re-interventions<br /><br>Stent obstruction or dysfunction<br /><br>Additionally, a quality of life and cost effectiveness analysis will be<br /><br>preformed with questionnaires. Validated questionnaires for quality of life,<br /><br>health state, work efforts and disabilities in daily life are measured by the<br /><br>Euro-Qol, SF-36 and *Werk en Zorg*.</p><br>